Abstract
AbstractComplete cardiac regeneration remains an elusive therapeutic goal. Although much attention has been focused on cardiomyocyte proliferation, especially in neonatal mammals, recent investigations have unearthed mechanisms by which non-cardiomyocytes, such as endothelial cells, fibroblasts, macrophages, and other immune cells, play critical roles in modulating the regenerative capacity of the injured heart. The degree to which each of these cell types influence cardiac regeneration, however, remains incompletely understood. This review highlights the roles of these non-cardiomyocytes and their respective contributions to cardiac regeneration, with emphasis on natural heart regeneration after cardiac injury during the neonatal period.
Publisher
Springer Science and Business Media LLC
Reference103 articles.
1. Virani, S. S. et al. Heart disease and stroke statistics-2021 update: a report from the american heart association. Circulation 143, e254–e743 (2021).
2. Heidenreich, P. A. et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American heart association. Circulation 123, 933–944 (2011).
3. Ahmad, M., Mehta, P., Reddivari, A. K. R. & Mungee, S. Percutaneous Coronary Intervention 1st edn (StatPearls Publishing, Treasure Island (FL), 2023).
4. Alexander, J. H. & Smith, P. K. Coronary-artery bypass grafting. N. Engl. J. Med. 374, 1954–1964 (2016).
5. Greene, S. J. et al. Medical therapy for heart failure with reduced ejection fraction. J. Am. Coll. Cardiol. 72, 351–366 (2018).